The Maryland company learned that FDA clearance was only the opening move. Its more durable play is connecting devices, care teams and everyday decisions - then selling that regulated intelligence through the institutions already paying for chronic care.
It made light bulbs, then TVs, then the CT scanner in your local hospital. The story of how a Dutch electronics giant reinvented itself as a pure health-tech company - and nearly lost the bet.
Baxter rarely gets the bedside spotlight. Its pumps, beds, monitors, medicines and IV bags are the practical infrastructure that lets modern care move - and the century-old company is rebuilding itself around a more connected hospital.
Eric Rock is the co-founder and CEO of Percipio Health, a Dallas-based company using AI and an ordinary smartphone - no medical devices - to collect whole-person health signals for scalable population health monitoring. A serial healthcare and technology entrepreneur, Rock previously founded ProHost (acquired by OpenTable), MEDHOST (a pioneering touchscreen emergency-department EMR), and Vivify Health, which grew into one of the largest remote patient monitoring platforms before Optum acquired it. Percipio launched in 2025 with $20M in Series A funding and a mission to bring proactive, low-cost care to entire populations.
Bloomlife is a San Francisco maternal health company that pairs FDA-cleared wearable sensors with a connected-care platform so high-risk pregnancies can be monitored from home. Born from a co-founder's own NICU experience, the company shifts prenatal care out of the clinic and into the living room - tracking fetal heart rate, blood pressure and glucose, then feeding the data to clinicians through risk-stratification tools meant to catch complications earlier.
Element Science is a San Francisco medical device and digital health company building the Jewel - a patch-based wearable cardioverter defibrillator that continuously monitors high-risk cardiac patients and delivers a life-saving shock when a lethal rhythm is detected. Founded in 2011 by Dr. Uday Kumar, the company combines clinical-grade wearables, machine learning, and human-centered design to protect patients with elevated, temporary risk of sudden cardiac arrest.
Eric Dy, PhD is the co-founder and CEO of Bloomlife, a San Francisco-based women's health company building connected care solutions for maternal and fetal monitoring. A biomedical engineer by training (Cornell BSc, UCLA MSc and PhD), Dy spent four years at IMEC - Europe's leading R&D institute - establishing 17 partnerships worth $25M+ in revenue before launching Bloomlife in 2014. His personal experience watching his wife navigate a high-risk pregnancy - gestational diabetes, preeclampsia, placental complications, preterm labor, and a son who spent his first month in the NICU - drove him to attack the most underserved gap in American healthcare. Bloomlife's FDA-cleared MFM-Pro wearable lets high-risk pregnant patients be monitored at home, replacing the endless clinic visits that define the current broken system. The company raised a $12.2M Series A in September 2024 and has secured reimbursement across 18 payers.